Global Equine Healthcare Market: Snapshot
The global equine healthcare market is
rising due to horse racing trend, global development programs for animal
health, and increasing incidence of equine infections. Presence of
various companies in the manufacturing of variety products in the market
will boost the consumption of the equine healthcare products. The
competition among the companies have led the companies to expand
geographically thus, boosting the market. These market strategies will
likely promote growth opportunities during the forecast period.
Report Overview @ https://www.transparencymarketresearch.com/equine-healthcare-market.html
Although the market is expected to face
certain restrains due to decreasing number of equine species worldwide,
the rise in demand for insurance of pet will potentially open new scope
for global equine healthcare market in the coming years.
According to a report by Transparency
Market Research, the global equine healthcare market is anticipated to
rise at a healthy CAGR of 4.2% during the forecast period of 2017 and
2025. The global market was worth US$601.7 mn during 2016 and is
expected to attain a valuation of US$ 862.7 mn by the end of 2025.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1603
The global equine healthcare market
according to product type is segmented into supplemental feed additives,
vaccines, and drugs. Among these, the drug segment held larger share in
2016. The rise was mainly due to high requirement of drug market for
the treatment of equines. The drug type is further segmented into
parasiticides, anti-inflammatory, and anti-infective. Among these drug
types, anti-infective has held larger share during 2016 and is expected
to rise during the forecast period. Drug segment is likely to rise due
to increased incidence of infections and the need for strong efficient
anti-infective drugs.
According to vaccines type, the global
equine healthcare market is segmented into recombinant, inactivated, and
live attenuated. Among these segments, inactivated segment held larger
share in the market during 2016. The rise in this segment is mainly due
to demand for safe vaccines.
The global equine healthcare market is
segmented according to disease type into equine herpes virus, equine
influenza, west Nile virus, equine encephalomyelitis, Potomac horse
fever, equine rabies, and tetanus.
The global equine healthcare market is
segmented according to channel into retail pharmacies and drug stores
and veterinary hospitals and clinics. The veterinary hospitals and
clinics distribution channel is expected to rise in the coming years due
to vast availability of vaccines and drugs.
Rising Growth Opportunities in North America and Europe to Remain Key in Global Market Development
The global equine healthcare market is
spread across various regions such as Asia Pacific, North America, Latin
America, Europe, and the Middle East & Africa. Among these, Europe
and North America is leading the market by holding larger shares in the
market. This region is anticipated to rise significantly during the
forecast period. Equines are facing high interest in equine care,
increased adoption rate of equines per household, strong business
operation of brand companies, and significant expenditure in animal
healthcare in these regions.
Asia pacific equine market held the next
largest share in 2016 and is expected to rise in the coming years due to
rising focus on healthcare of animals, emerging equine care trend,
increased expenses on animal healthcare products, and rising popularity
of horse racing.
Some of the leading companies operating
in the global equine healthcare market are Sanofi (Merial), Zoetis,
Vetoquinol S.A., Purina Animal Nutrition LLC., and Bayer AG.
No comments:
Post a Comment